Parabellum backs a Belgian anti-counterfeit specialist


Parabellum Investments has acquired Advanco to fight against fake drugs, as pharmaceutical companies race to develop vaccines against COVID-19. The Brussels-based business’ software allows manufacturers to track the serial numbers of medicine. The deal will allow the company to accelerate its international expansion. Advanco’s software is used by groups including Pfizer and Zentiva.

View full article: